These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 23812895)

  • 1. Innate immune responses in the CNS: role of toll-like receptors, mechanisms, and therapeutic opportunities in multiple sclerosis.
    Podda G; Nyirenda M; Crooks J; Gran B
    J Neuroimmune Pharmacol; 2013 Sep; 8(4):791-806. PubMed ID: 23812895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the innate immune system in autoimmune inflammatory demyelination.
    O'Brien K; Fitzgerald DC; Naiken K; Alugupalli KR; Rostami AM; Gran B
    Curr Med Chem; 2008; 15(11):1105-15. PubMed ID: 18473806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-mediated CNS damage.
    Kierdorf K; Wang Y; Neumann H
    Results Probl Cell Differ; 2010; 51():173-96. PubMed ID: 19130024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Close Encounters of the First Kind: Innate Sensors and Multiple Sclerosis.
    Fernández-Paredes L; de Diego RP; de Andrés C; Sánchez-Ramón S
    Mol Neurobiol; 2017 Jan; 54(1):101-114. PubMed ID: 26732593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate immune regulation of autoimmunity in multiple sclerosis: Focus on the role of Toll-like receptor 2.
    Hossain MJ; Tanasescu R; Gran B
    J Neuroimmunol; 2017 Mar; 304():11-20. PubMed ID: 28007303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate immunity in the central nervous system.
    Ransohoff RM; Brown MA
    J Clin Invest; 2012 Apr; 122(4):1164-71. PubMed ID: 22466658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Neuroprimer: Principles of Central Nervous System Immunity.
    Owens GP
    Semin Pediatr Neurol; 2017 Aug; 24(3):145-151. PubMed ID: 29103421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll like receptors: a new hope on the horizon to treat multiple sclerosis.
    Gooshe M; Aleyasin AR; Abdolghaffari AH; Rezaei N
    Expert Rev Clin Immunol; 2014 Oct; 10(10):1277-9. PubMed ID: 25161080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies in MS: mechanisms of action.
    Bielekova B; Becker BL
    Neurology; 2010 Jan; 74 Suppl 1(Suppl 1):S31-40. PubMed ID: 20038761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the innate and adaptive immune responses in the course of multiple sclerosis.
    Hemmer B; Kerschensteiner M; Korn T
    Lancet Neurol; 2015 Apr; 14(4):406-19. PubMed ID: 25792099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alemtuzumab: a further option for treatment of multiple sclerosis].
    Menge T; Kieseier BC; Warnke C; Aktas O; Hartung HP
    Nervenarzt; 2012 Apr; 83(4):487-501. PubMed ID: 22038387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The innate immunity of the central nervous system in chronic pain: the role of Toll-like receptors.
    Guo LH; Schluesener HJ
    Cell Mol Life Sci; 2007 May; 64(9):1128-36. PubMed ID: 17440679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptors in multiple sclerosis.
    Racke MK; Drew PD
    Curr Top Microbiol Immunol; 2009; 336():155-68. PubMed ID: 19688333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of natalizumab on the innate and adaptive immune system in the central nervous system.
    Stüve O
    J Neurol Sci; 2008 Nov; 274(1-2):39-41. PubMed ID: 18474372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Distinct Subsets of Macrophages in the Pathogenesis of MS and the Impact of Different Therapeutic Agents on These Populations.
    Radandish M; Khalilian P; Esmaeil N
    Front Immunol; 2021; 12():667705. PubMed ID: 34489926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury.
    Lehnardt S
    Glia; 2010 Feb; 58(3):253-63. PubMed ID: 19705460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspectives on cytokine-directed therapies in multiple sclerosis.
    Schreiner B; Becher B
    Swiss Med Wkly; 2015; 145():w14199. PubMed ID: 26495801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting innate receptors with MIS416 reshapes Th responses and suppresses CNS disease in a mouse model of multiple sclerosis.
    White M; Webster G; O'Sullivan D; Stone S; La Flamme AC
    PLoS One; 2014; 9(1):e87712. PubMed ID: 24498172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immune response in the CNS in Theiler's virus induced demyelinating disease switches from an early adaptive response to a chronic innate-like response.
    Gilli F; Li L; Pachner AR
    J Neurovirol; 2016 Feb; 22(1):66-79. PubMed ID: 26260496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptors in inflammation of the central nervous system.
    Kong Y; Le Y
    Int Immunopharmacol; 2011 Oct; 11(10):1407-14. PubMed ID: 21600311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.